Rajesh Janardhanan
Papers
1
Total Citations
11
H-Index
1
About
Rajesh Janardhanan is a pioneering cardiovascular researcher whose work bridges regenerative medicine and clinical cardiology. His most cited study, "First in Man: Adipose-derived Stromal Vascular Fraction Cells May Promote Restorative Cardiac Function" (2014), marked a landmark step in cell-based therapy for heart disease. This early-phase investigation demonstrated the safety and potential efficacy of using adipose-derived stromal vascular fraction cells to improve cardiac function after injury, offering a minimally invasive, autologous alternative to traditional stem cell approaches. With 11 citations, this proof-of-concept work has influenced subsequent trials exploring stromal cell therapies for myocardial repair. Janardhanan’s research focuses on harnessing the regenerative capacity of adipose tissue, addressing critical gaps in post-infarction heart failure treatment. His contributions lie at the intersection of translational science and patient-centered innovation, emphasizing scalable, accessible therapies. By advancing the clinical application of stromal vascular fraction cells, Janardhanan has helped lay the groundwork for a new class of cardiac regenerative interventions, inspiring further investigation into cell-based strategies for restoring heart function.
Research Focus
Key Achievements
Top Papers
- 1